16
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7530 |
PD146176
NSC168807 |
Ferroptosis; Lipoxygenase; Autophagy | Apoptosis; Autophagy; Metabolism |
PD146176 (NSC-168807) 是一种 15-脂氧合酶(15-LO)抑制剂,抑制兔网织红细胞 15-LO,Ki 为 197 nM,IC50 为 0.54 μM。 它通过刺激老年三重转基因小鼠的自噬来逆转认知障碍、脑淀粉样变性和 tau 病理学。 | |||
T0382 |
Eprodisate disodium
NC-503,伊罗地塞二钠,伊罗地塞二钠盐 |
Others | Others |
Eprodisate disodium (NC-503) 是一种带负电荷的磺化类的原纤维形成抑制剂,是口服具有活力的 Eprodisate 二钠盐形式,可用于研究淀粉样蛋白A(AA) 淀粉样变性病。 | |||
T14283 |
amyloid P-IN-1
|
Beta Amyloid | Neuroscience |
amyloid P-IN-1 可用于研究血清淀粉样蛋白 P 成分耗尽的疾病,例如阿尔茨海默病、淀粉样变性、骨关节炎和 2 型糖尿病。 | |||
T39740 |
Acoramidis hydrochloride
AG10 hydrochloride,Alxn2060 hydrochloride |
Others | Others |
Acoramidis hydrochloride (Alxn2060 hydrochloride) 是具有口服活性的、选择性的甲状腺素转运蛋白 (TTR (transthyretin)) 的稳定剂,对野生型和 V1221 突变型均有效。Acoramidis hydrochloride 可用于转体甲状腺素淀粉样变性的研究。 | |||
T9447 |
AG-10
Acoramidis |
Others | Others |
AG-10 (Acoramidis) 是选择性的、口服有效的甲状腺素转运蛋白 (TTR (transthyretin)) 的稳定剂,显示出对野生型和 V1221 突变型均有效。 | |||
T111959 |
IFB-088 acetate
|
||
IFB-088 acetate 是一种苄基胍衍生物,可用于治疗与PPP1R15A 途径相关并与蛋白质错误折叠应激相关的疾病和癌症,如tau 病、突触核蛋白病、多谷氨酰胺和多丙氨酸疾病、白质营养不良、囊性纤维化、多发性硬化症、溶酶体储存障碍、淀粉样变性疾病、炎症、代谢障碍、心血管疾病、骨质疏松症、神经系统创伤等等。 | |||
T38909 |
Inotersen sodium
ISIS-420915 sodium |
||
Inotersen sodium, also known as ISIS-420915 sodium, is a 2′-O-methoxyethyl-modified antisense oligonucleotide compound. It effectively inhibits transthyretin (TTR) protein production by targeting the TTR RNA transcript, thereby reducing TTR transcript levels. Inotersen sodium holds potential for research on hereditary TTR amyloidosis polyneuropathy. | |||
T39304 |
Vutrisiran
ALN-TTRsc02 |
||
Vutrisiran (ALN-TTRsc02) is an investigational, liver-directed small interfering ribonucleic acid (siRNA) compound designed for research on transthyretin (TTR)-mediated amyloidosis. | |||
T39638 |
Eprodisate
|
||
Eprodisate is a novel compound specifically developed to disrupt the interactions between amyloidogenic proteins and glycosaminoglycans, effectively impeding the polymerization of amyloid fibrils and their deposition in tissues. This compound shows potential for delaying the advancement of AA amyloidosis-related renal disease and could apply to various forms of amyloidosis. | |||
T38918 |
Revusiran
ALN-TTRSC |
||
Revusiran (ALN-TTRSC) is a first-generation short interfering RNA (siRNA) that specifically targets transthyretin (TTR) mRNA. It is utilized in TTR-mediated amyloidosis research. | |||
T79417 |
PITB
|
||
PITB是一种选择性且具口服活性的TTR聚集抑制剂,主要用于研究ATTR疾病。 | |||
T38804 | Patisiran sodium | ||
Patisiran sodium is a double-stranded small interfering RNA (siRNA) that selectively targets a specific sequence within the transthyretin (TTR) messenger RNA (mRNA). By doing so, it effectively blocks the hepatic synthesis of both mutant and wild-type TTR. Patisiran sodium has significant applications in the field of hereditary TTR amyloidosis research. | |||
T78531 | Anti-amyloid agent-1 | ||
Anti-amyloid agent-1是一种有效抗淀粉样蛋白化合物,能抑制淀粉样蛋白聚集,并为淀粉样变性治疗研究提供了有用的方法。 | |||
T76931 | Birtamimab | ||
Birtamimab (NEOD001) 为一研究性单克隆抗体,特异性且选择性地靶向并清除淀粉样蛋白,主要应用于轻链淀粉样变性的研究。 | |||
T80801 |
WAY-612453
|
||
WAY-612453是用于研究淀粉样蛋白疾病(Amyloidosis)及突触核蛋白病(Synucleinopathies)的活性分子。 | |||
T74645 | Eplontersen | ||
Eplontersen 是一种三触角的、N-乙酰半乳糖胺 (GalNAc3)-缀合的反义寡核苷酸,能够靶向 甲状腺素运载蛋白 TTR 的 mRNA,抑制变体和野生型 TTR 产生。错误折叠的 TTR 诱导心脏和周围神经的淀粉样原纤维形成,并介导淀粉样 TTR (ATTR) 蛋白变性疾病。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2532 |
Tauroursodeoxycholate
Taurolite,牛磺熊去氧胆酸,Tauroursodeoxycholic Acid,UR 906,Ursodeoxycholyltaurine,TUDCA |
Apoptosis; ERK; P450; Caspase; Endogenous Metabolite | Apoptosis; MAPK; Metabolism; Proteases/Proteasome |
Tauroursodeoxycholate (UR 906),又称 ursodoxicoltaurine,是一种高度亲水性的三级胆汁酸,在人体内以低浓度产生。Tauroursodeoxycholate 是 ursodeoxycholic acid 更亲水的形式,而 ursodeoxycholic acid 是人类体内自然产生的更丰富的胆汁酸。Tauroursodeoxycholate 正在研究用于几种疾病,如原发性胆汁性肝硬化(PBC)、胰岛素抵抗、淀粉样变性、囊性纤维化、胆汁淤滞和肌萎缩性侧索硬化症。 |